SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000921895-18-001238
Filing Date
2018-04-09
Accepted
2018-04-09 17:18:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g11247002_04092018.htm SC 13G 155537
2 JOINT FILING AGREEMENT ex991to13g11247002_040918.htm EX-99.1 6511
  Complete submission text file 0000921895-18-001238.txt   163710
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Subject) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87471 | Film No.: 18746314
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 MENACHEM BEGIN RD. RAMAT-GAN L3 5268104
Business Address 11 MENACHEM BEGIN RD. RAMAT-GAN L3 5268104 972-77-3206050
Brosh Capital Partners L.P. (Filed by) CIK: 0001703304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G